Treasurer of the State of North Carolina - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 421 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.00 and the average weighting 0.3%.

Quarter-by-quarter ownership
Treasurer of the State of North Carolina ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$7,505
+4.6%
61,912
-1.2%
0.04%
+7.9%
Q2 2023$7,176
-13.7%
62,662
+3.9%
0.04%
-19.1%
Q1 2023$8,312
+5.9%
60,307
-0.4%
0.05%
-2.1%
Q4 2022$7,850
-99.9%
60,577
+20.8%
0.05%
+29.7%
Q3 2022$5,543,000
+107.8%
50,147
+40.9%
0.04%
+117.6%
Q2 2022$2,668,000
+11.3%
35,597
+16.0%
0.02%
+30.8%
Q1 2022$2,397,000
-11.8%
30,683
+1.6%
0.01%
-7.1%
Q4 2021$2,719,000
+7.0%
30,198
+9.9%
0.01%
-6.7%
Q3 2021$2,542,000
+23.1%
27,488
+3.5%
0.02%
+25.0%
Q2 2021$2,065,000
+0.3%
26,559
-3.9%
0.01%
-7.7%
Q1 2021$2,059,000
-75.7%
27,629
-44.5%
0.01%
-76.8%
Q4 2020$8,487,000
+20.9%
49,780
-0.4%
0.06%
+5.7%
Q3 2020$7,020,000
-13.0%
49,990
-0.7%
0.05%
-20.9%
Q2 2020$8,072,000
+118.3%
50,340
+33.2%
0.07%
+103.0%
Q1 2020$3,698,000
+12.0%
37,800
+47.7%
0.03%
+22.2%
Q4 2019$3,303,000
+84.2%
25,600
+7.5%
0.03%
+68.8%
Q3 2019$1,793,000
-59.9%
23,810
-19.1%
0.02%
-40.7%
Q2 2019$4,470,000
+11.2%
29,420
-12.7%
0.03%
+3.8%
Q1 2019$4,018,000
+2.7%
33,710
-6.0%
0.03%
-10.3%
Q4 2018$3,914,000
-29.2%
35,869
+4.8%
0.03%
-17.1%
Q3 2018$5,528,000
+200.1%
34,224
+145.6%
0.04%
+84.2%
Q2 2018$1,842,00013,9360.02%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Perceptive Advisors 2,878,979$69,182,0007.27%
Eventide Asset Management 259,100$6,226,0000.97%
GLADE BROOK CAPITAL PARTNERS LLC 251,000$6,032,0000.93%
IMS Capital Management 32,215$774,0000.91%
Perceptive Advisors 350,000$8,413,0000.88%
Benchmark Capital Advisors 34,900$839,0000.58%
BECK CAPITAL MANAGEMENT, LLC 24,744$636,0000.49%
SABBY MANAGEMENT, LLC 352,100$8,461,0000.47%
Hatteras Alternative Mutual Funds, LLC 39,404$947,0000.46%
Potomac Capital Management, Inc. 22,100$531,0000.45%
View complete list of SAREPTA THERAPEUTICS INC shareholders